Clinical Trials Logo

Central Sleep Apnea, Secondary clinical trials

View clinical trials related to Central Sleep Apnea, Secondary.

Filter by:
  • None
  • Page 1

NCT ID: NCT02371473 Enrolling by invitation - Clinical trials for Central Sleep Apnea, Secondary

Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption

Start date: November 2014
Phase: Phase 4
Study type: Interventional

Acetazolamide improves central sleep apnea related to opium consumption.